Furthermore, CSF NfH and NfL levels seem to correlate with MS clinical course (higher levels in RR MS compared to CIS and in progressive compared to RR MS) and with disease activity (higher levels during relapses compared to remission phase). Here, NEFH is linked to myeloid sarcoma.